[Joint Statement on the New WHO Recommendations for Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis]

MeSH terms

• Antitubercular Agents / pharmacology
• Antitubercular Agents / therapeutic use*
• Humans
• Microbial Sensitivity Tests
• Mycobacterium tuberculosis / drug effects*
• Practice Guidelines as Topic*
• Rifampin / pharmacology*
• Treatment Outcome
• Tuberculosis, Multidrug-Resistant / drug therapy*
• World Health Organization